Abstract
Synthesis and evaluation of C-28 oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase have been described. The results of glycogen phosphorylase inhibition assay and structure-activity relationship (SAR) analysis are also discussed.
Keywords: Glycogen phosphorylase, Oleanolic acid, C-28 derivatives, Synthesis, Inhibition
Letters in Drug Design & Discovery
Title: Synthesis and Evaluation of C-28 Oleanolic Acid Derivatives as Inhibitors of Glycogen Phosphorylase
Volume: 7 Issue: 2
Author(s): Keguang Cheng, Chao Wang, Jun Liu, Juan Xie and Hongbin Sun
Affiliation:
Keywords: Glycogen phosphorylase, Oleanolic acid, C-28 derivatives, Synthesis, Inhibition
Abstract: Synthesis and evaluation of C-28 oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase have been described. The results of glycogen phosphorylase inhibition assay and structure-activity relationship (SAR) analysis are also discussed.
Export Options
About this article
Cite this article as:
Cheng Keguang, Wang Chao, Liu Jun, Xie Juan and Sun Hongbin, Synthesis and Evaluation of C-28 Oleanolic Acid Derivatives as Inhibitors of Glycogen Phosphorylase, Letters in Drug Design & Discovery 2010; 7 (2) . https://dx.doi.org/10.2174/157018010790225921
DOI https://dx.doi.org/10.2174/157018010790225921 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biological Activities of Quinoline Derivatives
Mini-Reviews in Medicinal Chemistry Congenital Anomalies of the Urinary Tract
Current Pediatric Reviews Role of Microtubules Network in CYP Genes Expression
Current Drug Metabolism Genetic-TLBO Algorithm for Power System Stabilizer
Current Signal Transduction Therapy Testosterone and Cardioprotection Against Myocardial Ischemia
Cardiovascular & Hematological Disorders-Drug Targets Podophyllotoxin: Current Perspectives
Current Bioactive Compounds Predicting COVID-19 Severity Integrating RNA-Seq Data Using Machine Learning Techniques
Current Bioinformatics Urine Cells-derived iPSCs: An Upcoming Frontier in Regenerative Medicine
Current Medicinal Chemistry Discovery and Advancement of Farnesyl Transferase Inhibitors as Potential Anticancer Therapeutic Agents: SCH 66336 a Case Study
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Discovery of Potential Compounds Against SARS-CoV-2 Based on 3CLpro/RdRp Dual-target: An <i>In silico</i> Approach
Letters in Drug Design & Discovery MicroRNA Polymorphisms, MicroRNA Pharmacogenomics and Cancer Susceptibility
Current Pharmacogenomics and Personalized Medicine Infection and Severity of COVID-19 Infection Among Healthcare Workers: A Report from Egypt
Infectious Disorders - Drug Targets Ionotropic Glutamate Receptors & CNS Disorders
CNS & Neurological Disorders - Drug Targets A Focus on Heme Oxygenase-1 (HO-1) Inhibitors
Current Medicinal Chemistry Estimation of Affinity of HLA-A*0201 Restricted CTL Epitope Based on the SCORE Function
Protein & Peptide Letters Flavonoids: Prospective Drug Candidates
Mini-Reviews in Medicinal Chemistry Editorial from Editor-in-Chief: Amniotic Pulmonary Embolism and the Respiratory System: Management Trends and Future Options
Current Respiratory Medicine Reviews Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors
Current Pharmaceutical Design COVID-19: Small-Molecule Clinical Trials Landscape
Current Topics in Medicinal Chemistry Recent Advances in Medicinal Chemistry of Sulfonamides. Rational Design as Anti-Tumoral, Anti-Bacterial and Anti-Inflammatory Agents
Mini-Reviews in Medicinal Chemistry